Lantheus Holdings, Inc.· LNTH
🇺🇸 US · MidSP400NASDAQ
- Price
- $101.11
- Day
- -0.08%
- Mkt Cap
- $6.58B
- 52W Range
- $47.25 – $111.86
- Volume
- 4.43M
- Beta
- -0.06
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments, subject to achievement of specified commercial milestones for Lantheus' products through 2030. Halper Sadeh encourages Lantheus shareholders to click here to learn more about the.
Read full article
BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), today announced that Curium US Holdings LLC (“Curium US”) and Lantheus have entered into a definitive agreement under which Lantheus, a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, will merge with a wholly-owned subsidiary of Curium US.
Read full article
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per sha
Read full article
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders PR Ne
Read full article
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026
Read full article
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) PR Newswire
Read full article
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Read full article
NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Lantheus Holdings, Inc. (NASDAQ: LNTH ) related to its sale to Curium US Holdings LLC.
Read full article
MILWAUKEE, Aug. 3, 2026 /PRNewswire/ -- Ademi LLP is investigating Lantheus (NASDAQ: LNTH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Curium. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Read full article
Curium said it would pay $102.50 a share in cash for Lantheus, a 2.9% premium to Friday's closing price of $99.64 and 8.5% above Lantheus's closing price of $94.47 on May 21, before Bloomberg reported that Curium was circling the company.
Read full article
Dimensional Fund Advisors LP trimmed its stake in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) by 2.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,379,570 shares of the medical equipment provider's stock after selling 35,893 shares during the period. Dimensional
Read full article
Terumo (OTCMKTS:TRUMY - Get Free Report) and Lantheus (NASDAQ: LNTH - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Profitability This table compares Terumo and Lantheus' net margins, return
Read full article